Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma.

We have implemented a three-dimensional dose calculation technique accounting for dose inhomogeneity within the liver and tumor of a patient treated with 90Y microspheres. Single-photon emission computed tomography (SPECT) images were used to derive the activity distribution within liver. A Monte Carlo calculation was performed to create a voxel dose kernel for the 90Y source. The activity distribution was convolved with the voxel dose kernel to obtain the three-dimensional (3D) radiation absorbed dose distribution. An automated technique was developed to accurately register the computed tomography (CT) and SPECT scans in order to display the 3D dose distribution on the CT scans. In addition, dose-volume histograms were generated to fully analyze the tumor and liver doses. The calculated dose-volume histogram indicated that although the patient was treated to the nominal whole liver dose of 110 Gy, only 16% of the liver and 83% of the tumor received a dose higher than 110 Gy. The mean tumor and liver doses were 163 and 58 Gy, respectively.

[1]  A. Li,et al.  Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours , 1996, European Journal of Nuclear Medicine.

[2]  Martin A Lodge,et al.  Automatic CT-SPECT registration of livers treated with radioactive microspheres. , 2004, Physics in medicine and biology.

[3]  K. Kandagatla,et al.  Beta voxel S values for internal emitter dosimetry. , 2003, Medical physics.

[4]  Cedric X. Yu,et al.  Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. , 2003, Medical physics.

[5]  Katherine S Panageas,et al.  Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Daniel Normolle,et al.  Analysis of radiation-induced liver disease using the Lyman NTCP model. , 2002, International journal of radiation oncology, biology, physics.

[7]  M. Burton,et al.  Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. , 2001, Physics in medicine and biology.

[8]  A. Li,et al.  Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. , 1998, International journal of radiation oncology, biology, physics.

[9]  G Sgouros,et al.  Implementation and evaluation of patient-specific three-dimensional internal dosimetry. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  G. van Hazel,et al.  Regression of liver metastases following treatment with yttrium-90 microspheres. , 2010, The Australian and New Zealand journal of surgery.

[11]  P. Roberson,et al.  Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  M. Burton,et al.  Dose distribution following selective internal radiation therapy. , 1991, International journal of radiation oncology, biology, physics.

[13]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[14]  David W. O. Rogers,et al.  Presta: The parameter reduced electron-step transport algorithm for electron monte carlo transport , 1986 .

[15]  H. Ing,et al.  A short atlas of beta-ray spectra , 1983 .